Ferro Pfanstiehl Labs, Inc., part of the Organic Specialties Group of Ferro Corp., has commissioned a new cGMP supercritical fluid-based particle engineering pilot facility. The facility brings additional expertise in particle sizing, purification and formulation to fee-for-service pharmaceutical and biopharmaceutical customers. It will provide ICH Q7A-compliant small-scale manufacturing of drug particles and compounds for use in Phase I and II trials and feasibility studies of engineered partic...